The present invention provides soluble forms of CD39L3 polypeptides and compositions, and methods useful inhibiting platelet activation and recruitment for the treatment and prevention of thrombotic disorders in mammals administered with soluble forms of CD39L3 polypeptides.

 
Web www.patentalert.com

> Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition

~ 00367